The document discusses improving patient adherence to medical treatment through the coordinated efforts of multiple stakeholders. It describes how health literacy is essential for adherence and how patient advocacy empowers patients. It then provides examples of how physicians, nurses, pharmacists, insurers, family/friends, policymakers, pharmaceutical companies, and patient associations can help change patient behavior to increase adherence. The overall conclusion is that adherence requires advocacy initiatives from across healthcare to help patients comply with treatment recommendations.
This session on safety was presented to the International Council of Nurses audience in Durban, South Africa. This is just a sample of the entire session; for more information on safety in the workplace, contact sharonw@corelimited.com
This session on safety was presented to the International Council of Nurses audience in Durban, South Africa. This is just a sample of the entire session; for more information on safety in the workplace, contact sharonw@corelimited.com
At the end of the session patient/ family/ advisors/ champions as well as health providers/ leaders/ authorities will leave with at least one practical idea to advance patient engagement in medication safety as a result of their increased understanding of:
. the role and responsibilities of patients/ families in medication safety
. different approaches to patient engagement in medication safety
. influencing factors (e.g. health literacy, culture, organizational and public policy)
. supporting resources and leading practices
Antimicrobial resistance is one of the biggest threats to human health and is rising to dangerously high levels in all parts of the world. Anyone, of any age, in any country, could be impacted. While it's normal for microbes to develop resistance to drugs, the way antimicrobials are currently being used is accelerating the process, and as a result common infections and minor injuries are becoming an increasingly greater threat to our well-being. Organizations from across the world are taking action and making progress on this issue, but is there anything patients, their families and patient advisors can do to help?
See the full presentation here: https://goo.gl/AYCsdd
How to Reduce Readmissions by Changing Patient EducationChuck Jones
The challenge is no longer finding the perfect medication but rather convincing the patient to take their medication as prescribed. It's no longer providing discharge instructions but educating the patient so they understand the need to follow through on behavior change to avoid repeating habits that brought them to the hospital in the first place.
20 tendencias digitales en salud digital_ The Medical FuturistRichard Canabate
Resaltado de las tendencias que darán forma a la atención médica post COVID19.
No se trata de enumerar estas tendencias, sino de dar una valiosa visión de los factores de conducción detrás de ellas mientras que es muy específico. Se trata de mostrar cuáles son las áreas exactas que deben destacarse entre todas las áreas en el tema "IA en la atención médica", por ejemplo.
Nieslen and IMS research findings from the new survey Understanding Trust in Over-the-Counter Medicines: Consumer and Healthcare Provider Perspectives.
Video: https://youtu.be/Yv6L_b8ZrtU
Abstract:
Asthma, chronic pulmonary disease, is one of the major health issues in the United States. Given its chronic nature, the demand for continuous monitoring of patient’s adherence to the medication care plan, assessment of their environment triggers, and management of asthma control level can be challenging in traditional clinical settings and taxing on clinical professionals. A shift from a reactive to a proactive asthma care can improve health outcomes and reduce expenses. On the technology spectrum, smart conversational systems and Internet-of-Things (IoTs) are rapidly gaining popularity in the healthcare industry. By leveraging such technological prevalence, it is feasible to design a system that is capable of monitoring asthmatic patients for a prolonged period and empowering them to manage their health better.
In this thesis, we describe kBot, a knowledge-driven personalized chatbot system designed to continuously track medication adherence of pediatric asthmatic patients (age 8 to 15) and monitor relevant health and environmental data. The outcome is to help asthma patients self manage their asthma progression by generating trigger alerts and educate them with various self-management strategies. kBOT takes the form of an Android application with a frontend chat interface capable of conversing both text and voice-based conversations and a backend cloud-based server application that handles data collection, processing, and dialogue management. The domain knowledge component is pieced together from the Asthma and Allergy Foundation of America, Mayoclinic, and Verywell Health as well as our clinical collaborator. Whereas, the personalization aspect is derived from the patient’s history of asthma collected from the questionnaires and day-to-day conversations. The system has been evaluated by eight asthma clinicians and eight computer science researchers for chatbot quality, technology acceptance, and system usability. kBOT achieved an overall technology acceptance score of greater than 8 on an 11-point Likert scale and a mean System Usability Score (SUS) greater than 80 from both evaluation groups.
https://www.facebook.com/pg/Kno.e.sis/photos/?tab=album&album_id=2560068547361311
Even if you aren't in medical school yet, it's never too early to start thinking about what type of healthcare specialty appeals to you. In this webinar, we chat with AUC graduates about what it's like to specialize in pediatrics.
Presentation created for Jordi Serrano Pons who was invited to present at the ITU Experts Group Meeting held within the framework of the ITU European Regional Initiative on ICT Applications, including e-Health.
Topic of the meeting:
M-HEALTH: TOWARDS BETTER CARE, CURE AND PREVENTION IN EUROPE
At the end of the session patient/ family/ advisors/ champions as well as health providers/ leaders/ authorities will leave with at least one practical idea to advance patient engagement in medication safety as a result of their increased understanding of:
. the role and responsibilities of patients/ families in medication safety
. different approaches to patient engagement in medication safety
. influencing factors (e.g. health literacy, culture, organizational and public policy)
. supporting resources and leading practices
Antimicrobial resistance is one of the biggest threats to human health and is rising to dangerously high levels in all parts of the world. Anyone, of any age, in any country, could be impacted. While it's normal for microbes to develop resistance to drugs, the way antimicrobials are currently being used is accelerating the process, and as a result common infections and minor injuries are becoming an increasingly greater threat to our well-being. Organizations from across the world are taking action and making progress on this issue, but is there anything patients, their families and patient advisors can do to help?
See the full presentation here: https://goo.gl/AYCsdd
How to Reduce Readmissions by Changing Patient EducationChuck Jones
The challenge is no longer finding the perfect medication but rather convincing the patient to take their medication as prescribed. It's no longer providing discharge instructions but educating the patient so they understand the need to follow through on behavior change to avoid repeating habits that brought them to the hospital in the first place.
20 tendencias digitales en salud digital_ The Medical FuturistRichard Canabate
Resaltado de las tendencias que darán forma a la atención médica post COVID19.
No se trata de enumerar estas tendencias, sino de dar una valiosa visión de los factores de conducción detrás de ellas mientras que es muy específico. Se trata de mostrar cuáles son las áreas exactas que deben destacarse entre todas las áreas en el tema "IA en la atención médica", por ejemplo.
Nieslen and IMS research findings from the new survey Understanding Trust in Over-the-Counter Medicines: Consumer and Healthcare Provider Perspectives.
Video: https://youtu.be/Yv6L_b8ZrtU
Abstract:
Asthma, chronic pulmonary disease, is one of the major health issues in the United States. Given its chronic nature, the demand for continuous monitoring of patient’s adherence to the medication care plan, assessment of their environment triggers, and management of asthma control level can be challenging in traditional clinical settings and taxing on clinical professionals. A shift from a reactive to a proactive asthma care can improve health outcomes and reduce expenses. On the technology spectrum, smart conversational systems and Internet-of-Things (IoTs) are rapidly gaining popularity in the healthcare industry. By leveraging such technological prevalence, it is feasible to design a system that is capable of monitoring asthmatic patients for a prolonged period and empowering them to manage their health better.
In this thesis, we describe kBot, a knowledge-driven personalized chatbot system designed to continuously track medication adherence of pediatric asthmatic patients (age 8 to 15) and monitor relevant health and environmental data. The outcome is to help asthma patients self manage their asthma progression by generating trigger alerts and educate them with various self-management strategies. kBOT takes the form of an Android application with a frontend chat interface capable of conversing both text and voice-based conversations and a backend cloud-based server application that handles data collection, processing, and dialogue management. The domain knowledge component is pieced together from the Asthma and Allergy Foundation of America, Mayoclinic, and Verywell Health as well as our clinical collaborator. Whereas, the personalization aspect is derived from the patient’s history of asthma collected from the questionnaires and day-to-day conversations. The system has been evaluated by eight asthma clinicians and eight computer science researchers for chatbot quality, technology acceptance, and system usability. kBOT achieved an overall technology acceptance score of greater than 8 on an 11-point Likert scale and a mean System Usability Score (SUS) greater than 80 from both evaluation groups.
https://www.facebook.com/pg/Kno.e.sis/photos/?tab=album&album_id=2560068547361311
Even if you aren't in medical school yet, it's never too early to start thinking about what type of healthcare specialty appeals to you. In this webinar, we chat with AUC graduates about what it's like to specialize in pediatrics.
Presentation created for Jordi Serrano Pons who was invited to present at the ITU Experts Group Meeting held within the framework of the ITU European Regional Initiative on ICT Applications, including e-Health.
Topic of the meeting:
M-HEALTH: TOWARDS BETTER CARE, CURE AND PREVENTION IN EUROPE
Bringing Researchers, Families/ Patients, and Providers Together to Improve Asthma Care.
Panelists: Flory Nkoy, MD, MS, MPH (Principal Investigator); Joseph Johnson, MD (PCP Stakeholder); Jordan Gaddis (Parent Stakeholder)
Presented at the 11th Annual HSR/ PCOR Conference: Partnering for Better Health: Bringing Utah's Patient Voices to Research 2016
Tom Deblanco: maximising patient engagementNuffield Trust
Tom Delbanco, MD, MACP and Koplow–Tullis, Professor of Medicine, Harvard Medical School present on maximising patient engagement through health information technology.
Partnering with Patients: Designing, Participating in and Reporting Health Ou...patvocates
Partnering with Patients: Designing, Participating in and Reporting Health Outcomes - presented by Jan Geissler at ISPOR 19th ANNUAL CONGRESS in Dublin on 6 Nov 2013
The benefits of patient involvement in research and development (RE:ACT Congr...jangeissler
Presentation of Jan Geissler, Director EUPATI and Co-Founder CML Advocates Network, about the benefits of involving patients in research and development, and about EUPATI. Held at RE:ACT Conress 2016 on Research of Rare and Orphan Diseases, organized by the Blackswan Foundation on 12 March 2016 in Barcelona, Spain
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...MyMeds&Me
MyMeds&Me CEO Andrew Rut proposes the debate motion, “With the changes in society and increased use of electronic media, the role of the health professional in Yellow Card reporting will be diminished” at the MHRA Scientific Conference in Edinburgh - this year commemorating the 50th anniversary of the Yellow Card reporting scheme.
It is well recognized that patient reports enhance signal detection and enable earlier recognition of safety issues . Given the significant level of under-reporting of adverse events by HCPs (Only between <1% - 6% of suspected ADRs experienced by patients are reported) and the apparent appetite from patients to share their experiences, as seen in social media and patient forums globally, we believe that we need to simplify reporting processes and enable all patients to report online with ease.
Clean data direct from source, without alteration, is the life-blood of drug safety organisations. PV specialists evaluating the safety of medicines rely upon rapid access to clean, complete, consistent data from source and patients ultimately are that source. It is essential to capture this data and therefore build a true picture for future signal detection activities.
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...patvocates
Patient Advocates in Cancer Research: European Patients’ Perspective, presented by Jan Geissler (Twitter @jangeissler) at ISOQOL 19th Annual Conference, Budapast, 26 Oct 2012
Patient View - The need for user-defined guidelines for health appsIn The Pocket
Dee O' Sullivan is an advocate for user-defined guidelines for health apps. In this presentation, she tells us why these guidelines are an absolute need in the healthcare industry.
The Role Of Telehealth In Emerging Models Of CareYasnof
Between 2006 and 2036 the proportion of New Zealand’s population aged 65 or over as a proportion of the working-age population is expected to rise from 18 to 40%,” The number of people over Chronic conditions are estimated to account for 70 percent of health funding and 80 percent of all deaths in New Zealand and health workforce numbers per person are expected to decrease over next 20 years. This presentation explores the potential of Telehealth to address these challenges
The development of a Patient Safety Programme for Primary Care is being informed by the learning from two ongoing primary care safety projects. This session highlights the approaches used, the early findings and describes how to sustain and spread the success of this work.
· For this assignment you will use the Quantitative and the QualitLesleyWhitesidefv
· For this assignment you will use the Quantitative and the Qualitative article that you submitted for week 4 assignment that were related to your week 2 picot question.
· Only articles you uploaded and used in week 4 (Quantitative or Qualitative) are to be submitted. Articles must be current (within the last 5 years). All articles must be related to the field of nursing and related to the topic list from week 2.
· Write a summary (one to two pages)
· In the summary identify differences in article designs and research methods. Describe the differences in your articles designs and methods. Carefully review the rubric before you submit. This summary is using your own words to examine the differences specifically between the articles.
· Use current APA style for your summary paper and to cite your sources.
· Submit the Articles and the summary, APA Format
Week 4 assignment articles used are attached separately
Week 2 Assignment PICOT Questions:
Question 1: In nurses with acute stress, how does mindfulness plan compared to relaxing to music reduce an individual's stress symptoms?
Question 2: how do first-time mothers of premature babies in NICU overcome postnatal stress during the first two months after birth?
Question 3: How does the use of exercises compare to medication in reducing stress among elderly people?
RESEARCH ARTICLE Open Access
Mixed feelings: general practitioners’
attitudes towards eHealth for stress urinary
incontinence - a qualitative study
Lotte Firet* , Chrissy de Bree, Carmen M. Verhoeks, Doreth A. M. Teunissen and Antoine L. M. Lagro-Janssen
Abstract
Background: Stress urinary incontinence (SUI) is the most prevalent subtype of urinary incontinence and is a bothering
condition in women. Only a minority of those with SUI consult a general practitioner (GP). EHealth with pelvic
floor muscle training (PFMT) is effective in reducing incontinence symptoms and might increase access to care.
The role of the GP regarding such an eHealth intervention is unknown. The aim of the study is to gain insight
into the attitudes towards a PFMT internet-based, eHealth, intervention for SUI.
Methods: A qualitative study was conducted. Data were collected through semi-structured interviews among
purposively sampled GPs. Audio records were fully transcribed, and analysed thematically.
Results: Thirteen GPs were interviewed, nine females and four males. Three themes emerged: appraisal of eHealth as a
welcome new tool, mixed feelings about a supportive role, and eHealth is no cure-all. GPs welcomed eHealth for SUI
as matching their preferences for PFMT and having advantages for patients. With eHealth as stand-alone therapy GPs
were concerned about the lack of feedback, and the loss of motivation to adhere to the intervention. Therefore, GPs
considered personal support important. The GP’s decision to recommend eHealth was strongly influenced by
a woman’s motivation and her age. GPs’ treatment preferences for elderly are d ...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
"Patient involvement in medicines R&D: Here we are, and where we want to be in 2020" by Nicola Bedlington, Executive Director of European Patients' Forum and Coordinator of the EUPATI project, at the EUPATI 2013 Conference on 19 April 2013.
Similar to Adherencia al Tratamiento. Dr. Antjefink Wagner (20)
Sesión Académica del CRAIC "Hipersensibilidad a Beta lactámicos"ß-lactámicos son los
antimicrobianos más utilizados
Se descubrieron desde 1928
Beneficiando la resolución de
múltiples padecimientos infecciosos, adquiridos en la comunidad o infecciones nosocomiales.
El grupo de ßlactámicos incluyen:
Penicilinas
Cefalosporinas
Carbapenémicos
Monobactámicos
Inhibidores de ß-Lactamasa
Sesión Académica del CRAIC "Hipersensibilidad a anticonvulsivantes"
Introducción
La epilepsia es uno de los principales problemas neurológicos tanto en países en
desarrollo como desarrollados 50 millones de personas padecen
epilepsia en todo el mundo
El tratamiento óptimo de la epilepsia requiere reconocimiento adecuado del tipo de crisis y el FAE con dosis segura y bien tolerada
FAE: fármaco antiepiléptico
Fenobarbital
Ácido valproico
Carbamazepina
Fenitoína
Los FAE convencionales aún se usan entre todos los grupos de edad, pese a su alta toxicidad y potencial de hipersensibilidad...
Sesión de Aerobiología del CRAIC "Ácaro, perro, gato y cucaracha"
Los ácaros de polvo son quizás
los maestros de la alergenicidad
La reactividad a sus productos
es de las causas más comunes
de alergia afectando ojos, vías
respiratorias superiores e
inferiores, piel y, en ocasiones,
la circulación sistémica.
Producen una variedad inigualable de alérgenos y adyuvantes perfectamente adecuados para inducir tanto reacciones inmunitarias innatas como adaptativas
Producen diversos alérgenos que no solo son inmunogénicos, sino que a menudo tienen actividad
proteolítica y se agregan con ADN bacteriano, endotoxinas, quitina y otros materiales que inducen
respuestas inmunitarias...
Sesión Académica del CRAIC "Reacciones de hipersensibilidad a AINEs"
Antiinflamatorios no
esteroideos (AINEs)
• Medicamentos que se administran con más
frecuencia
• Efectos antipiréticos,
analgésicos y
antiinflamatorios
Todas las personas están
expuestas a un AINE al
menos una vez
Forma rutinaria
• Sin ninguna alternativa
Brindan alivio sin inducir sedación como los analgésicos narcóticos
Ni causar efecto secundarios
sistémicos importantes como los
esteroides
Manifestaciones alérgicas de errores innatos de la inmunidad
¿Qué es un error innato de la
inmunidad?
• Grupo de enfermedades
causadas por defectos
genéticos que generan
disfunción inmunitaria
Tienen una tendencia inusual a infecciones recurrentes
y/o graves
Sin embargo, las enfermedades alérgicas se reportan con
frecuencia y podrían ser la primera manifestación clínica
No se ha establecido de
forma clara la prevalencia y
características de estos
pacientes.
El resultado es un retraso en el diagnóstico o un
diagnóstico erróneo en algunos casos
La alergia como manifestación inicial de EII se reporta hasta en 8 % de los pacientes (5-25 %)
Esto influye de forma directa en el retraso en el diagnóstico de EII hasta en 7.5 % de los
casos
La inmunodeficiencia común variable es un claro ejemplo, con un retraso en el diagnóstico que
varía desde 6 hasta 10 años
Sesión Académica del CRAIC
"Reacciones adversas cutáneas graves"
Alergia a medicamentos: reacción que se suscita
posterior a la ingesta de algún medicamento en el
que está implicado un mecánismo inmunológico
• Las reacciones adversas a medicamentos se definen
como reacciones inesperadas y dañinas a una dosis
de medicamento convencional.
• Las reacciones adversas a medicamentos se originan
por diferentes mecanismos y provocan diversas
manifestaciones clínicas.
Predecibles Tipo A
• Constituyen 85-90 % de todas
las reacciones adversas a
medicamentos
• Mecanismo: farmacodinamia y
farmacocinética
• Afectan a cualquier individuo
• Dependen de la dosis
• Predecibles por las propiedades
farmacológicas
Impredecibles Tipo B
• 15-20 %
• Independiente de la dosis
• Mecanismo: hipersensibilidad
immune/no inmune
• Activación sistema immune o sus
vías
• 1. Intolerancia
2. Reacciones idiosincrásicas
3. Reacciones inmunológicas
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Adherencia al Tratamiento. Dr. Antjefink Wagner
1. Adherence to Treatment
Adherencia al Tratamiento
Antje-Henriette Fink-Wagner, PhD
Executive Director
Global Allergy and Asthma Patient Platform GAAPP
Antje-Henriette Fink-Wagner, 2012 1
3. – Status of Health Literacy as relevant issue to be adherent/
concordant
– Patient advocacy as 1st step to empower patients and to
increase adherence/concordance for better patient compliance
– Integral meaning and consequences of compliance
– Model of patient behavior
– Integration of all stakeholders to change patient behavior
– Conclusion
Examples: – Physician
– Nurse
– Pharmacist
– Insurance/funds
– Family and friends
– Policy Makers
– Pharmaceutical industry
– Patient associations
Content
or what you will take home from this presentation
Antje-Henriette Fink-Wagner, 2012 3
4. – Literacy and misunderstanding prescription drug labels.
Annals of Internal Medicine 2006 :
Take two tablets twice daily.
How many patients can follow this direction?
Health Literacy
a precondition to achieve acceptable adherence/concordance
Antje-Henriette Fink-Wagner, 2012 4
5. – Literacy and misunderstanding prescription drug labels.
Annals of Internal Medicine 2006 :
Take two tablets twice daily.
How many patients can follow this direction?
Only 34 % of patients were able to accurately follow this!
Health Literacy
a precondition to achieve acceptable adherence/concordance
Antje-Henriette Fink-Wagner, 2012 5
6. Patient advocacy as 1st step to empower patients and
to increase adherence/concordance for better patient
compliance
– Advocacy empowers patients
– Empowered patients are more willing to feel responsible
for their therapy
– Patients who feel responsible want to understand
therapy opportunities, which means they request
education
– Educated patients are able to adhere to doctors‘ advice on
a level of concordance
– Concordance
will increase compliance
Patient advocacy will increase compliance
Antje-Henriette Fink-Wagner, 2012 6
8. Source: N. Barber, J. Parsons, S. Clifford, R. Darracott, R. Horne; Qual Saf Health Care
2004; 13: 172-175, doi: 10.1136/ qshc.2003.005926
Still taking medication at 10 days
(n = 226/239)
Still taking medication at 4 weeks
(n = 171/197)
Adherent
Non-adherent
Partial non-adherence
Complete non-adherence
159 (70%)
67 (30%)
49
18
128 (75%)
43 (25%)
26
17
Adherence to new medication:
Patients‘ problems with new medication
for chronic conditions
Antje-Henriette Fink-Wagner, 2012 8
9. Source: F.A. Al-Eidan et al. J Clin Pharmacol 2002, 53, 163-171
Example
Compliance with and without help taking
medication in Hp eradication therapy
Antje-Henriette Fink-Wagner, 2012 9
10. Valerie uses her spray
twice daily –
without any relief!
… without any problems?
Antje-Henriette Fink-Wagner, 2012 10
11. Model of patient behavior
Levendahl, et al. stated 1992:
Patients personal ideas
about their illness are often
organized around five
components:
– Identity
– Timeline
– Cause
– Consequences
– Control/cure
These can be thought of
as the answers to five basic
questions about the illness
or health threat:
– What is it?
– How long will it last?
– What causes it?
– How will it/has it affected me?
– Can it be controlled or cured?
People form a mental model or representation of the illness,
which is made up of their answers to these questions.
Antje-Henriette Fink-Wagner, 2012 11
13. Physician
Motivational interviewing: Ask open questions in
Patient friendly language
What changes would you most like to talk about?
What have you noticed about…….?
How important is it for you to change…?
How confident do you feel about changing…?
How do you see the benefits
Source:
Physician
Antje-Henriette Fink-Wagner, 2012 13
BMJ 2010
14. Physician
Physician
Motivational interviewing
Develop Discrepancy
– How does current behavior
conflict with core values?
Minimize Unsolicited Advice
– Patients overcomes their own obstracles
– Dance not a wrestling match
Support Self-Efficacy
– Uncover and reinforce it
Usual Suspects
– Express empathy
– Good nonverbal listening skills
– Be a problem solving partners Antje-Henriette Fink-Wagner, 2012 14
15. Physician
Physician
Never forget the WRITTEN action plan!
Red Zone: Stop! Danger!
Yellow Zone: Caution! Slow Down!
Green Zone: Go!
Antje-Henriette Fink-Wagner, 2012 15
17. NurseExample: Nurse
Phone Dialog
doctor – patient – nurse triangle
COPD case management
by National Jewish Medical
and Research Center
– Individualized by patient and physician
– Driven by action plans from physician
– Nurses handle calls based on
developed algorithms as kind of call center
– Inbound and outbound calls
through Case Manager (nurse)
– Physicians always notified
– Can be done every 12 or 24 hours and will be
less after few weeks
Antje-Henriette Fink-Wagner, 2012 17
18. National Jewish Medical and Research Center
COPD all plan members
12-month utilization data
0 Adult Days Missed
from Work
n = 272
500
1500
ER Visits
n = 751
Hospitalizations
n = 751
Unscheduled Dr. Visits
n = 751
Oral Antibiotic Bursts
n = 746
1383
245
164
582
Baseline
7 to 12 Months
p < 0.001
1000
756
-79.7%
281
-70.7%
48
- 48.2%
127
-58.9%
239
-45.1%
415
Source: Data provided by David Tinkelman, vice president Health Initiatives NJC, December 2002
NurseExample: Nurse
Antje-Henriette Fink-Wagner, 2012 18
20. PharmacistExample: Pharmacist
EFA Allergy Awareness Project 2011-2014:
Pharmacists are the first Health Care Professionals
seeing a patient on risk for allergies when asking for
OTC products.
Situation: People often “know” they have an allergy but
do not go for proper diagnosis.
Aim: Use pharmacists to motivate potential allergy
patients to visit a doctor for proper diagnosis and
therapy.
Pilot project planed in Austria and Germany to proof
positive role of pharmacists in 2013.
Antje-Henriette Fink-Wagner, 2012 20
23. Source: Techniker Krankenkasse, 2005; www.tk-online.de
Example: Insurance/Funds
Reminder service
Reminder service for preventive measures
of members
– Dental prophylaxis
– Health check-up
– Cancer prophylaxis
– Preventive care for children and youths
– Smoking cessation
Telephone reminder or information by e-mail
as requested by the member
Insurance/
Funds
Antje-Henriette Fink-Wagner, 2012 23
24. Source: Techniker Krankenkasse, www.tk-online.de, Januar 2005
Example: Insurance/Funds
Diagnostic information for members
– After online entry of a diagnosis (often provided in codes only),
a diagnosis text is displayed in patient friendly language
– including additional information, e.g. links to treatment guidelines
Insurance/
Funds
Antje-Henriette Fink-Wagner, 2012 24
25. Source: Chest 2011
Insurance/Funds
The impact of co pay costs on non adherence Insurance/
Funds
Antje-Henriette Fink-Wagner, 2012 25
Rates of cost-related non-adherence (black bars) by monthly out-of-pocket
inhaler costs in the Inhaler +/CPD+ group. There is a roughly linear increases in
cost –related non-adherence as the out-of-pocket costs of inhalers increases
(test for trend, P<.0001). Error bars represent SEM.
27. Example: Family and Friends
Smoking cessation
“Feel free to say no”,
an initiative of the European Union:
Testimonials presents the friends
of the target groups
Antje-Henriette Fink-Wagner, 2012 27
28. Paul, hurry!
You have to be at
the doctor’s
at eleven …
Memory function …
Family
and
Friends
Antje-Henriette Fink-Wagner, 2012 28
29. Conclusion
How can patient behavior be changed
Public/
Policy Makers
Antje-Henriette Fink-Wagner, 2012 29
30. Policy Makers
Health Literacy: a precondition to achieve acceptable
adherence/concordance
Public
Policy Makers
Antje-Henriette Fink-Wagner, 2012 30
European Health Award October 2012 :
• Survey of the HLS-EU CONSORTIUM
Source: HLS-EU CONSORTIUM (2012): COMPARATIVE REPORT OF HEALTH LITERACY IN EIGHT EU MEMBER STATES. THE EUROPEAN HEALTH LITERACY SURVEY HLS-EU , ONLINE PUBLICATION:
HTTP://WWW.HEALTH-LITERACY.EU
About 12% of
respondents
have inadequate general
health literacy, and more
than one third (35%)
problematic health
literacy, thus nearly
every second respondent
shows limited health
literacy,
in the general sample.
8000 respondents from
8 countries.
31. Joint messages in as many countries
As possible
Public
World Awareness days
Public
Policy Makers
Creates awareness about a special
disease to patients, public and Policy Makers
Antje-Henriette Fink-Wagner, 2012 31
32. Conclusion
How can patient behavior be changed
Pharma-
ceutical
Industry
Antje-Henriette Fink-Wagner, 2012 32
33. Pharma-
ceutical
Industry
Example: Pharmaceutical Industry
ZacPac
History
3 packages to eradicate Hp:
PPI plus two different antibiotics
(French triple therapy)
Compliance friendly solution
Development of ONE compliance-supporting
medication package for all three drugs
– Received the international award
Antje-Henriette Fink-Wagner, 2012 33
34. Example: Technical Industry
Helping Hand™
– Electronic tool offered
by Bang & Olufsen
– Reminds patients to take
medication correctly
– Helps patients to feel secure on
level of compliance
– In use for 4 indications
(CNS, cardiovascular,
osteoporosis, immune suppression)
– Improves compliance from
45 – 80% and 95% of doctors
believe patients benefit from it
– Increased persistence
affects market shares
(according to B&O)
Pharma-
ceutical
Industry
Antje-Henriette Fink-Wagner, 2012 34
35. Conclusion
How can patient behavior be changed
Patient
Associations
Antje-Henriette Fink-Wagner, 2012 35
36. Patient Association
European Federation of Allergy and Airways
Diseases Patient Associations EFA
– 32 Member organizations in 22 countries
– EFA Respiratory Allergy Awareness Project:
– Raise awareness of respiratory allergies (Rhinoconjunctivitis and
Allergic Asthma Rhinitis, Asthma) as serious chronic disease
– Call for
– Early identification of symptoms by target audience
– Early diagnosis and appropriate strategies including life style changes
and physical activities to manage and control allergic diseases to
– Avoid exacerbations of severe allergies
Patient
Associations
Antje-Henriette Fink-Wagner, 2012 36
37. EFA Call to Action
– EU policy-makers are called to coordinate actions to
1) Increase the political recognition of respiratory allergies as a
real and serious disease
2) Promote national programmes on respiratory allergies
3) Prioritize the management and control of respiratory allergies
4) Promote training in allergy for healthcare professionals to
improve accurate and early diagnosis
5) Align healthcare and reimbursement policies, to support
appropriate disease management
6) Improve indoor air quality
Invitation to sign the EFA Call to Action:
http://www.efacallaction.net/sign.aspx Antje-Henriette Fink-Wagner, 2012
38. Patient
Associations
Patient Association
Global Allergy and Asthma Patient Platform
– 24 member organizations on all
Continents
– Sport Games for children with asthma to promote
adherence to sport for asthmatics (see first talk of this
session)
Antje-Henriette Fink-Wagner, 2012 38
39. Conclusion
Adherence / Concordance will improve
as the sum of individual advocacy initiatives
by all allied healthcare professionals and the
patients themselves.
Antje-Henriette Fink-Wagner, 2012 39